Liquid-biopsy Informed Platform Trial to Evaluate CDK4/6-inhibitor Resistant ER+/HER2- Metastatic Breast Cancer
Clinical trial NCT05601440 · RECRUITING
Trial details
- NCT number
- NCT05601440
- Sponsor
- Canadian Cancer Trials Group
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-06-13
- Primary completion
- 2027-12-31
- Enrollment
- 484
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.